I think that the market finally realise that PNO's analgesic compound(Tripeptofen) will have a relatively short time frame to become commercially available because of the fact that it is the active ingredient of the approved Thermalife.
The market for a new fast acting analgesic is large. Quote.
"The realisation of a potentially new and important analgesic
compound has encouraged Pharmanet to adopt an aggressive and European focused regulatory
approval program. The analgesic market is currently estimated at €30 billion annually."
- Forums
- ASX - By Stock
- running
I think that the market finally realise that PNO's analgesic...
Featured News
Add CAI (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable